BLOG
July 3, 2018
As we’ve discussed, no purchasing department is immune to human error. During the course of normal operation, a health system is bound to overpay for an item here or there. However, we see all too often cases where these errors add up over time, costing the system thousands in lost revenue. At The Audit Group, we perform detailed pricing reviews to identify areas of overpayment, as well as pricing claims to route those funds back to the hospital. How TAG Conducts A Pricing Review To begin a pricing review, our team will receive a data download from the health system: […]
June 20, 2018
The 340B Drug Discount Program offers qualified hospitals deeply discounted rates on drugs, but many aren’t using the program to its maximum benefit. A 340B pricing analysis from an experienced healthcare auditor can reveal several errors in your drug pricing and prevent you from leaving money on the table. Let’s take a look. 340B Program Challenges Just because your health system is eligible for 340B doesn’t mean it’s a turnkey process. The government and drug manufacturers adjust the pricing guidelines for 340B products every quarter, keeping back-office teams on their toes to update each item’s pricing as needed. That creates […]
